Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

22.100
+0.2501.14%
Volume:5.56M
Turnover:122.35M
Market Cap:131.19B
PE:28.19
High:22.200
Open:21.950
Low:21.750
Close:21.850
Loading ...

Hansoh Pharma's HS-20093 Drug Gets Another Breakthrough Therapy Designation in China

MT Newswires Live
·
18 Apr

BRIEF-Hansoh Pharmaceutical's Targeted Antibody Drug Conjugate Gets NMPA Breakthrough-Therapy-Designated-Drug

Reuters
·
17 Apr

Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated-Drug for B7-H3-Targeted Antibody-Drug Conjugate Hs-20093

THOMSON REUTERS
·
17 Apr

Hansoh Pharma Gets Clinical Trial Nod in China for Cancer Drug

MT Newswires Live
·
16 Apr

BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10529 Tablets Issued By NMPA

Reuters
·
15 Apr

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-10529 Tablets Issued by Nmpa

THOMSON REUTERS
·
15 Apr

Hansoh Pharmaceutical Gets China Nod for Trial of Two Tumor Drugs

MT Newswires Live
·
08 Apr

BRIEF-Hansoh Pharmaceutical Gains Clinical Trial Approval For HS-20108

Reuters
·
07 Apr

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-20108 for Injection Issued by Nmpa

THOMSON REUTERS
·
07 Apr

Greater China Stocks Slip; Taiwan Sees Largest Decline

Dow Jones
·
31 Mar

Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.86 From HK$18.36, Keeps at Neutral

MT Newswires Live
·
24 Mar

Hansoh Pharmaceutical's 2024 Profit Jumps 33%

MT Newswires Live
·
24 Mar

BRIEF-Hansoh Pharmaceutical Posts FY Revenue Of RMB 12,261 Million

Reuters
·
21 Mar

BRIEF-Hansoh Pharmaceutical Recommends Final Dividend Of HK$13.53 Cents Per Share

Reuters
·
21 Mar

Hansoh Pharmaceutical - Board Recommends a Final Dividend of HK$13.53 Cents per Share

THOMSON REUTERS
·
21 Mar

Hansoh Pharmaceutical Group Company FY Net Income RMB 4,372 Million

THOMSON REUTERS
·
21 Mar

Hansoh Pharmaceutical Gets Registration Go-Ahead for Third Indication of Cancer Drug

MT Newswires Live
·
11 Mar

BRIEF-Hansoh Pharmaceutical Says NMPA Granted Drug Registration Approval Of Third Indication Of Ameile

Reuters
·
10 Mar

Hansoh Pharmaceutical - Drug Registration Approval of Third Indication of Ameile (Aumolertinib Mesilate Tablets) Granted by Nmpa

THOMSON REUTERS
·
10 Mar

Greater China Stocks Slip; Hong Kong Sees Largest Decline

Dow Jones
·
10 Mar